Risk Factors for Drug-resistant Streptococcus pneumoniae and Antibiotic Prescribing Practices in Outpatient Community-acquired Pneumonia

被引:32
|
作者
Jenkins, Timothy C. [1 ,2 ,6 ,7 ]
Sakai, Joy [6 ]
Knepper, Bryan C. [3 ]
Swartwood, Claire J. [4 ,8 ]
Haukoos, Jason S. [5 ,9 ,10 ]
Long, Jeremy A. [1 ,6 ]
Price, Connie S. [1 ,2 ,6 ,7 ]
Burman, William J. [1 ,2 ,6 ,7 ]
机构
[1] Denver Hlth Med Ctr, Dept Med, Denver, CO USA
[2] Denver Hlth Med Ctr, Div Infect Dis, Denver, CO USA
[3] Denver Hlth Med Ctr, Dept Patient Safety & Qual, Denver, CO USA
[4] Denver Hlth Med Ctr, Dept Pharm, Denver, CO USA
[5] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO USA
[6] Univ Colorado Denver, Dept Med, Aurora, CO USA
[7] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA
[8] Univ Colorado Denver, Dept Pharm, Aurora, CO USA
[9] Univ Colorado Denver, Dept Emergency Med, Aurora, CO USA
[10] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA
关键词
ANTIMICROBIAL RESISTANCE; FLUOROQUINOLONES; EMERGENCE;
D O I
10.1111/j.1553-2712.2012.01365.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: Due to antimicrobial resistance in Streptococcus pneumoniae, national guidelines recommend a respiratory fluoroquinolone or combination antimicrobial therapy for outpatient treatment of community-acquired pneumonia (CAP) associated with risk factors for drug-resistant S. pneumoniae (DRSP). The objectives of this study were to assess the prevalence of these risk factors and antibiotic prescribing practices in cases of outpatient CAP treated in the acute care setting. Methods: This was a retrospective cohort study of adult outpatients treated for CAP in the emergency department (ED) or urgent care center of an urban, academic medical center from May 1, 2009, through October 31, 2009, and comparison of antibiotic therapy in cases with and without DRSP risk factors. Results: Of 175 patients, 90 (51%) had at least one DRSP risk factor, most commonly asthma (n = 28, 16%), alcohol abuse (n = 24, 14%), diabetes mellitus (n = 18, 10%), chronic obstructive pulmonary disease (n = 16, 9%), age > 65 years (n = 16, 9%), and use of antibiotics within 3 months (15, 9%). Antibiotic prescriptions were similar among cases with and without DRSP risk factors: a macrolide (62% vs. 59%, respectively, p = 0.65), doxycycline (27% vs. 28%, p = 0.82), or a respiratory fluoroquinolone (9% vs. 9%, p = 0.90). Concordance with national guideline treatment recommendations was significantly lower in cases with DRSP risk factors (9% vs. 87%, p < 0.0001). Conclusions: DRSP risk factors were present in approximately half of outpatient CAP cases treated in the acute care setting; however, guideline-concordant antibiotic therapy was infrequent. Strict adherence to current guidelines would substantially increase use of fluoroquinolones or combination therapy. Whether the potential risks associated with these broad-spectrum regimens are justified by improved clinical outcomes requires further study. ACADEMIC EMERGENCY MEDICINE 2012; 19: 703-706 (C) 2012 by the Society for Academic Emergency Medicine
引用
收藏
页码:703 / 706
页数:4
相关论文
共 50 条
  • [41] The clinical significance of Streptococcus pneumoniae resistance in community-acquired pneumonia
    Manika, Katerina
    Kioumis, Ioannis
    PNEUMON, 2011, 24 (04) : 379 - 391
  • [42] Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia
    R. Chokshi
    M. I. Restrepo
    N. Weeratunge
    C. R. Frei
    A. Anzueto
    E. M. Mortensen
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 447 - 451
  • [43] Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia
    Chokshi, R.
    Restrepo, M. I.
    Weeratunge, N.
    Frei, C. R.
    Anzueto, A.
    Mortensen, E. M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (07) : 447 - 451
  • [44] Incidence of drug-resistant pathogens in community-acquired pneumonia at a safety net hospital
    Ding, Helen
    Mang, Norman S.
    Loomis, Jordan
    Ortwine, Jessica K.
    Wei, Wenjing
    O'Connell, Ellen J.
    Shah, Nainesh J.
    Prokesch, Bonnie C.
    MICROBIOLOGY SPECTRUM, 2024, 12 (08):
  • [45] Patterns of antibiotic prescribing in treating community-acquired pneumonia outpatients
    Wu, Y
    Cislo, P
    Boening, A
    Mukherjee, J
    L'Italien, G
    VALUE IN HEALTH, 2003, 6 (03) : 253 - 253
  • [46] Appropriateness of antibiotic prescribing in community-acquired pneumonia at a tertiary hospital
    Pena-Lorenzo, D.
    Rebollo-Diaz, N.
    Martin-Gil, M.
    Beunza-Sola, M.
    Fernandez-Caballero, R.
    Martin-Munuz, R.
    Blanco-Serrano, B.
    Otero-Lopez, M. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, 41 (01) : 351 - 352
  • [47] THE IMPACT OF ANTIMICROBIAL STEWARDSHIP ON ANTIBIOTIC PRESCRIBING FOR COMMUNITY-ACQUIRED PNEUMONIA
    Clifford, L.
    Lee, R.
    RESPIROLOGY, 2021, 26 : 69 - 69
  • [48] Antibiotic-Resistant Community-Acquired Bacterial Pneumonia
    Ho, Jeffery
    Ip, Margaret
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2019, 33 (04) : 1087 - +
  • [49] Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia
    Rothberg, Michael B.
    Haessler, Sarah
    Deshpande, Abhishek
    Yu, Pei-Chun
    Lindenauer, Peter K.
    Zilberberg, Marya D.
    Higgins, Thomas L.
    Imrey, Peter B.
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2023, 44 (07) : 1143 - 1150
  • [50] Principles of antibiotic treatment of community-acquired pneumonia in the outpatient setting
    Segreti, J
    House, HR
    Siegel, RE
    AMERICAN JOURNAL OF MEDICINE, 2005, 118 : 21 - 28